Nattokinasa
Resumen de Efectividad y Riesgos
Condición | Efectividad | Detalles |
---|---|---|
Problemas de Coagulación Sanguínea | Nattokinase has been shown to have fibrinolytic activity, breaking down blood clots and improving circulation. Clinical studies support its use in conditions related to blood clotting. | |
Prevención de Trombosis | Nattokinase's ability to break down fibrin clots can help prevent thrombosis. Studies have demonstrated its effectiveness in reducing thrombus formation. | |
Trombosis de Vena Profunda (TVP) | The fibrinolytic activity of nattokinase may help prevent or treat DVT by dissolving blood clots. Evidence from clinical studies supports its potential benefits. | |
Aterosclerosis | Nattokinase may help in reducing the progression of atherosclerosis by improving fibrinolysis and blood flow. Preliminary studies are promising, but more research is required. | |
Prevención del Accidente Cerebrovascular | By reducing blood clot formation and improving circulation, nattokinase may help prevent stroke. Clinical evidence is supportive, but further studies are needed to establish its role fully. | |
Hipertensión (Presión Arterial Alta) | Some studies indicate that nattokinase can help lower blood pressure, possibly by improving vascular health and reducing blood viscosity. However, evidence is not yet conclusive. | |
Enfermedad Cardiovascular | By improving blood flow and reducing blood clot formation, nattokinase may contribute to cardiovascular health. Some studies suggest benefits, but more research is needed to confirm its effects on overall cardiovascular disease. | |
Puede interactuar mal con anticoagulantes.<EXPL-La actividad fibrinolítica de la nattokinasa puede aumentar el riesgo de sangrado cuando se toma con medicamentos anticoagulantes, como la warfarina.</EXPL> | — |
Suplemento Recomendado